Study Report

Basic Info
Reference |
Graae, L.,2012 PMID: 22389694
|
Citation |
Graae, L., R. Karlsson, et al. (2012). "Significant association of estrogen receptor binding site variation with bipolar disorder in females." PLoS One 7(2): e32304.
|
Disease Type |
Bipolar Disorder |
Study Design |
case-control |
Study Type |
Candidate-gene association study |
Sample Size |
964 cases diagnosed with bipolar disorder and 998 healthy controls |
SNP/Region/Marker Size |
435,291 SNPs |
Predominant Ethnicity |
Caucasian |
Population |
European |
Gender |
487 women and 477 men in patients with bipolar disorder and 490 women and 508 men for controls |

Detail Info
Sample Diagnosis |
DSM |
Sample Status |
The individuals included in the study on bipolar disorder come from the National Institute of Mental Health Human Genetics Initiative (NIMH GI; http://nimhgenetics.org/). Cases used within our study are individuals with European Ancestry that have been collected and characterized by the NIMH GI for Bipolar Disorder Consortium (Bipolar consortium). The cases were diagnosed with a standard best estimate final diagnosis(BEFD) procedure and interviewed with the Diagnostic Interview for Genetic Studies (DIGS). The control subjects, also of European ancestry, were collected separately through a NIMH-supported contract mechanism between Dr. Pablo Gejman and Knowledge Networks, Inc. |
Technique |
Genotyping |
Statistical Method |
Perl scripts were written for all data manipulation and PLINK,a free, open-source whole genome association analysis toolset(http://pngu.mgh.harvard.edu/,purcell/plink/), was used for additional quality control steps, association analysis, and statistical calculations. |
Result Summary |
Association studies were performed within each gender separately and the results were corrected for multiple testing by the Bonferroni method. In the female bipolar disorder material a significant association result was found for rs6023059 (corrected p-value = 0.023; odds ratio (OR) 0.681, 95% confidence interval (CI) 0.570-0.814), a single nucleotide polymorphism (SNP) placed downstream of the gene coding for transglutaminase 2 (TGM2). Thus, females with a specific genotype at this SNP may be more vulnerable to fluctuating estrogen levels, which may then act as a triggering factor for bipolar disorder. |

SNPs reported by this study for BD (count: 3)
SNP |
Related Gene(s) |
Allele Change |
Risk Allele |
Statistical Values |
Author Comments |
Result Category |
rs867286 |
PRKCE
|
A/G |
|
Association analysis: for female, P-value corrected with Bonferroni correction=0.16
|
No significant association was observed in BD.
No significant association was observed in BD.
|
Negative
|
rs6517590 |
DSCAM
|
A/G |
|
Association analysis: for male, P-value corrected with Bonferroni correction=0.1
|
No significant association was observed in BD.
No significant association was observed in BD.
|
Negative
|
rs6023059 |
RPRD1B
TGM2
|
C/T |
|
Association analysis: for female, P-value corrected with Bonferroni correction=0.023; ; odds ratio (OR) 0.681, 95% confidence interval (CI) 0.570-0.814
|
Significant association was observed in BD.
Significant association was observed in BD.
|
Positive
|

Genes reported by this study for BD (count: 3)
Gene |
Statistical Values/Author Comments |
Result Category |
TGM2 |
Supportive evidence for significant association findings was also observed.
Supportive evidence for significant association findings was also observed.
|
Positive
|
DSCAM |
No significant association was observed in BD.
No significant association was observed in BD.
|
Negative
|
PRKCE |
No significant association was observed in BD.
No significant association was observed in BD.
|
Negative
|